BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30619462)

  • 1.
    Olson CO; Pejhan S; Kroft D; Sheikholeslami K; Fuss D; Buist M; Ali Sher A; Del Bigio MR; Sztainberg Y; Siu VM; Ang LC; Sabourin-Felix M; Moss T; Rastegar M
    Front Genet; 2018; 9():635. PubMed ID: 30619462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREB Signaling Is Involved in Rett Syndrome Pathogenesis.
    Bu Q; Wang A; Hamzah H; Waldman A; Jiang K; Dong Q; Li R; Kim J; Turner D; Chang Q
    J Neurosci; 2017 Mar; 37(13):3671-3685. PubMed ID: 28270572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MeCP2E1/E2-BDNF-
    Pejhan S; Del Bigio MR; Rastegar M
    Front Cell Dev Biol; 2020; 8():763. PubMed ID: 32974336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
    Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
    Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
    Braunschweig D; Simcox T; Samaco RC; LaSalle JM
    Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
    Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
    Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes.
    Lamonica JM; Kwon DY; Goffin D; Fenik P; Johnson BS; Cui Y; Guo H; Veasey S; Zhou Z
    J Clin Invest; 2017 May; 127(5):1889-1904. PubMed ID: 28394263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
    Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
    Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
    Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
    Mol Autism; 2017; 8():56. PubMed ID: 29090078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome.
    Li MR; Pan H; Bao XH; Zhang YZ; Wu XR
    J Hum Genet; 2007; 52(1):38-47. PubMed ID: 17089071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
    Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
    Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation spectrum and genotype-phenotype correlation of MECP2 in patients with Rett syndrome].
    Kondo I; Yamagata H
    No To Hattatsu; 2002 May; 34(3):219-23. PubMed ID: 12030010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological reactivation of inactive X-linked
    Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Sensitivity of the Protein Translation Initiation Machinery and mTOR Signaling to
    Buist M; El Tobgy N; Shevkoplyas D; Genung M; Sher AA; Pejhan S; Rastegar M
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of MECP2 mutations in Rett syndrome.
    Bienvenu T; Villard L; De Roux N; Bourdon V; Fontes M; Beldjord C; Tardieu M; Jonveaux P; Chelly J;
    Genet Test; 2002; 6(1):1-6. PubMed ID: 12180070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface- and voxel-based brain morphologic study in Rett and Rett-like syndrome with MECP2 mutation.
    Shiohama T; Levman J; Takahashi E
    Int J Dev Neurosci; 2019 Apr; 73():83-88. PubMed ID: 30690146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
    LaSalle JM; Goldstine J; Balmer D; Greco CM
    Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2.
    Thatcher KN; LaSalle JM
    Epigenetics; 2006; 1(1):24-31. PubMed ID: 17464364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
    Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
    Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.